These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28293169)

  • 1. Brain Metabolism Changes in Patients Infected with HTLV-1.
    Schütze M; Romanelli LC; Rosa DV; Carneiro-Proietti AB; Nicolato R; Romano-Silva MA; Brammer M; de Miranda DM
    Front Mol Neurosci; 2017; 10():52. PubMed ID: 28293169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).
    Romanelli LCF; Miranda DM; Carneiro-Proietti ABF; Mamede M; Vasconcelos HMM; Martins ML; Ferreira ASD; Rosa DVF; Paula JJ; Romano-Silva MA; Nicolato R
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006720. PubMed ID: 30148843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Nakamura T; Nishiura Y; Eguchi K
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
    Kira J; Fujihara K; Itoyama Y; Goto I; Hasuo K
    J Neurol Sci; 1991 Nov; 106(1):41-9. PubMed ID: 1779238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
    Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.
    Silva MT; Mattos P; Alfano A; Araújo AQ
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1085-9. PubMed ID: 12876239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypometabolism of watershed areas of the brain in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Taniguchi A; Mochizuki H; Nagamachi S; Ebihara Y; Ishii N; Shiomi K; Nakazato M
    Neurol Sci; 2015 Nov; 36(11):2117-20. PubMed ID: 26156876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delimitation of the upstream region of NFKBIA gene associated with HTLV-1-associated myelopathy/tropical spastic paraparesis using candidate Tag-SNPs in Peruvian HTLV-1 infected individuals.
    Posadas AE; Rosado JJ; Gotuzzo E; Talledo MJ
    Infect Genet Evol; 2019 Nov; 75():103929. PubMed ID: 31226330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
    Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.